Matrix metalloproteinase-2 promoter genotype as a marker of cutaneous T-Cell lymphoma early stage

Journal of Biomedicine and Biotechnology

Volumn 2010, Issue , 2010, Pages

  Vasku, Anna ^a   Vasku, Julie Bienertova ^a   Nečas, Miroslav ^a   Vasku, Vladimir ^a  

^a MASARYK UNIVERSITY   (Czech Republic)

Author keywords

[No Author keywords available]

Indexed keywords

GELATINASE A; GENOMIC DNA; RETINOID; STEROID; TUMOR MARKER;

ADULT; AGED; ARTICLE; CANCER RISK; CANCER STAGING; CONTROLLED STUDY; CUTANEOUS T CELL LYMPHOMA; DNA POLYMORPHISM; FEMALE; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; PARAPSORIASIS; PHOTOTHERAPY; PROMOTER REGION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SENSITIVITY AND SPECIFICITY; CASE CONTROL STUDY; ENZYMOLOGY; GENETIC PREDISPOSITION; GENETICS; MIDDLE AGED; PATHOLOGY; SKIN TUMOR;

ADULT; AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LYMPHOMA, T-CELL, CUTANEOUS; MALE; MATRIX METALLOPROTEINASE 2; MIDDLE AGED; NEOPLASM STAGING; PARAPSORIASIS; PROMOTER REGIONS, GENETIC; SKIN NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 77955365237     PISSN: 11107243     EISSN: 11107251     Source Type: Journal    
DOI: 10.1155/2010/805907     Document Type: Article

References (19)

1. Hauzenberger D., Bergstr̈m S. E., Klominek J., Sundqvist K. G., Spectrum of extracellular matrix degrading enzymes in normal and malignant T lymphocytes Anticancer Research 1999 19 3 1945 1952
2. Nabeshima K., Suzumiya J., Nagano M., Ohshima K., Toole B. P., Tamura K., Iwasaki H., Kikuchi M., Emmprin, a cell surface inducer of matrix metalloproteinases (MMPs), is expressed in T-cell lymphomas Journal of Pathology 2004 202 3 341 351
3. Vacca A., Moretti S., Ribatti D., Pellegrino A., Pimpinelli N., Bianchi B., Bonifazi E., Ria R., Serio G., Dammacco F., Progression of mycosis fungoides is associated with changes in angiogenesis and expression of the matrix metalloproteinases 2 and 9 European Journal of Cancer 1997 33 10 1685 1692
4. Vacca A., Ribatti D., Ria R., Pellegrino A., Bruno M., Merchionne F., Dammacco F., Proteolytic activity of human lymphoid tumor cells. Correlation with tumor progression Developmental Immunology 2000 7 24 77 88
5. Hahtola S., Tuomela S., Elo L., Hkkinen T., Karenko L., Nedoszytko B., Heikkil H., Saarialho-Kere U., Roszkiewicz J., Aittokallio T., Lahesmaa R., Ranki A., Th1 response and cytotoxicity genes are down-regulated in cutaneous T-cell lymphoma Clinical Cancer Research 2006 12 16 4812 4821
6. Arlt M., Kopitz C., Pennington C., Watson K. L. M., Krell H.-W., Bode W., Gansbacher B., Khokha R., Edwards D. R., Krger A., Increase in gelatinase-specificity of matrix metalloproteinase inhibitors correlates with antimetastatic efficacy in a T-cell lymphoma model Cancer Research 2002 62 19 5543 5550
7. Krger A., Arlt M. J. E., Gerg M., Kopitz C., Bernardo M. M., Chang M., Mobashery S., Fridman R., Antimetastatic activity of a novel mechanism-based gelatinase inhibitor Cancer Research 2005 65 9 3523 3526
8. Kashani-Sabet M., McMillan A., Zackheim H. S., A modified staging classification for cutaneous T-cell lymphoma Journal of the American Academy of Dermatology 2001 45 5 700 706
9. Vak A., Goldbergov M., Holl L. I., ikov L., Groch L., Bernek M., Tschplov S., Znojil V., Vcha J., A haplotype constituted of four MMP-2 promoter polymorphisms (-1575G/A, -1306C/T, -790T/G and -735C/T) is associated with coronary triple-vessel disease Matrix Biology 2004 22 7 585 591
10. Sarveswari K. N., Yesudian P., The conundrum of parapsoriasis versus patch stage of mycosis fungoides Indian Journal of Dermatology, Venereology and Leprology 2009 75 3 229 235
11. Santucci M., Biggeri A., Feller A. C., Massi D., Burg G., Efficacy of histologic criteria for diagnosing early mycosis fungoides: an EORTC cutaneous lymphoma study group investigation American Journal of Surgical Pathology 2000 24 1 40 50
12. Bernier C., Nguyen J.-M., Qureux G., Renault J.-J., Bureau B., Dreno B., CD13 and TCR clone: markers of early mycosis fungoides Acta Dermato- Venereologica 2007 87 2 155 159
13. Harendza S., Lovett D. H., Panzer U., Lukacs Z., Khnl P., Stahl R. A. K., Linked common polymorphisms in the gelatinase a promoter are associated with diminished transcriptional response to estrogen and genetic fitness The Journal of Biological Chemistry 2003 278 23 20490 20499
14. Price S. J., Greaves D. R., Watkins H., Identification of novel, functional genetic variants in the human matrix metalloproteinase-2 gene. Role of Sp1 in allele-specific transcriptional regulation The Journal of Biological Chemistry 2001 276 10 7549 7558
15. Deniaud E., Baguet J., Mathieu A.-L., Pags G., Marvel J., Leverrier Y., Overexpression of Sp1 transcription factor induces apoptosis Oncogene 2006 25 53 7096 7105
16. Segre J. A., Bauer C., Fuchs E., Klf4 is a transcription factor required for establishing the barrier function of the skin Nature Genetics 1999 22 4 356 360
17. Evans P. M., Chen X., Zhang W., Liu C., KLF4 interacts with -catenin/TCF4 and blocks p300/CBP recruitment by -catenin Molecular and Cellular Biology 2010 30 2 372 381
18. Wu B., Crampton S. P., Hughes C. C. W., Wnt signaling induces matrix metalloproteinase expression and regulates T cell transmigration Immunity 2007 26 2 227 239
19. Fuchs O., EVI1 and its role in myelodysplastic syndrome, myeloid leukemia and other malignant diseases Casopis Lekaru Ceskych 2006 145 8 619 624